Kin Kui Lai

662 total citations
12 papers, 419 citations indexed

About

Kin Kui Lai is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Kin Kui Lai has authored 12 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Epidemiology and 5 papers in Immunology. Recurrent topics in Kin Kui Lai's work include interferon and immune responses (5 papers), Influenza Virus Research Studies (4 papers) and HIV Research and Treatment (3 papers). Kin Kui Lai is often cited by papers focused on interferon and immune responses (5 papers), Influenza Virus Research Studies (4 papers) and HIV Research and Treatment (3 papers). Kin Kui Lai collaborates with scholars based in United States, Hong Kong and China. Kin Kui Lai's co-authors include Alex A. Compton, Guoli Shi, Adam D. Kenney, Ashley Zani, Jacob S. Yount, Luanne Hall‐Stoodley, Kwok‐Yung Yuen, Dmitri S. Kudryashov, Lizhi Zhang and Elena Kudryashova and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The EMBO Journal.

In The Last Decade

Kin Kui Lai

11 papers receiving 413 citations

Peers

Kin Kui Lai

ID

IMMUN

EPIDE

MB

PHEOH

Ching-Ping Chan Hong Kong

Cuiji Lin China

Luis Adrián De Jesús‐González Mexico

Jessie Kulsuptrakul United States

Carlos Noe Farfán-Morales Mexico

Jennifer Tisoncik-Go United States

Cromwell Cornillez-Ty United States

Carlos Daniel Cordero‐Rivera Mexico

K. Haist United States

Raquel Amorim Canada

Ching-Ping Chan Hong Kong

Kin Kui Lai

249 ×1.2

ID

139 ×1.0

IMMUN

80 ×0.6

EPIDE

112 ×1.0

MB

95 ×0.9

PHEOH

Citations per year, relative to Kin Kui Lai Kin Kui Lai (= 1×) peers Ching-Ping Chan

Countries citing papers authored by Kin Kui Lai

Since Specialization

Citations

This map shows the geographic impact of Kin Kui Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kin Kui Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kin Kui Lai more than expected).

Fields of papers citing papers by Kin Kui Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kin Kui Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kin Kui Lai. The network helps show where Kin Kui Lai may publish in the future.

Co-authorship network of co-authors of Kin Kui Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Kin Kui Lai. A scholar is included among the top collaborators of Kin Kui Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kin Kui Lai. Kin Kui Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Agarwal, Mahesh, et al.. (2025). Restriction of HIV-1 infectivity by interferon and IFITM3 is counteracted by Nef. Science Advances. 11(40). eadz7083–eadz7083.

2.

Lai, Kin Kui, Siddhartha A.K. Datta, Demetria Harvin, et al.. (2024). Essential functions of inositol hexakisphosphate (IP6) in murine leukemia virus replication. mBio. 15(7). e0115824–e0115824. 1 indexed citations

3.

Mak, N. K., Jingyan Liu, Dan Zhang, et al.. (2024). Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe bats. PLoS Pathogens. 20(12). e1012763–e1012763. 1 indexed citations

4.

Shi, Guoli, Tiansheng Li, Kin Kui Lai, et al.. (2024). Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue. Nature Communications. 15(1). 889–889. 15 indexed citations

5.

Leonhardt, Susan A., Michael D. Purdy, Jonathan R. Grover, et al.. (2023). Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry. Nature Communications. 14(1). 4368–4368. 16 indexed citations

6.

Lai, Kin Kui, James B. Munro, Guoli Shi, et al.. (2022). Restriction of Influenza A Virus by SERINC5. mBio. 13(6). e0292322–e0292322. 10 indexed citations

7.

Shi, Guoli, Abhilash I. Chiramel, Tiansheng Li, et al.. (2022). Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. Journal of Clinical Investigation. 132(24). 24 indexed citations

8.

Yang, Fang, Bo Pang, Kin Kui Lai, et al.. (2021). Discovery of a Novel Specific Inhibitor Targeting Influenza A Virus Nucleoprotein with Pleiotropic Inhibitory Effects on Various Steps of the Viral Life Cycle. Journal of Virology. 95(9). 20 indexed citations

9.

Shi, Guoli, Adam D. Kenney, Elena Kudryashova, et al.. (2020). Opposing activities of IFITM proteins in SARS‐CoV‐2 infection. The EMBO Journal. 40(3). e106501–e106501. 162 indexed citations

10.

Chan, Jasper Fuk‐Woo, Kenn Ka‐Heng Chik, Shuofeng Yuan, et al.. (2017). Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor. Antiviral Research. 141. 29–37. 98 indexed citations

11.

Lai, Kin Kui, Jun Dai, Kin Hang Kok, et al.. (2017). Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response. Journal of General Virology. 98(5). 946–954. 45 indexed citations

12.

Lai, Kin Kui, Fang Yang, Jun Dai, et al.. (2015). Identification of Novel Fusion Inhibitors of Influenza A Virus by Chemical Genetics. Journal of Virology. 90(5). 2690–2701. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact